Michael Dollin

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Progression of Geographic Atrophy in Age-related Macular Degeneration

Tiarnán D L Keenan, Elvira Agrón, Amitha Domalpally et al. · Ophthalmology · 2018 · 201 citations

Ocular Disease, Age-related Diseases, Geographic Atrophy +1

The Role of Topical Antibiotic Prophylaxis to Prevent Endophthalmitis after Intravitreal Injection

Philip Storey, Michael Dollin, John D. Pitcher et al. · Ophthalmology · 2013 · 161 citations

Vitreous Body, Ophthalmology, Antibiotics +10

Paracentral Acute Middle Maculopathy in Nonischemic Central Retinal Vein Occlusion

Ehsan Rahimy, David Sarraf, Michael Dollin et al. · American Journal of Ophthalmology · 2014 · 134 citations

Ocular Disease, Retina, Vitreous Body +6